Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 0.037\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) CC1CCN(CCCCOc2ccc(Cl)cc2)CC1.O=C(O)C(=O)O
b) S=C(NCCc1c[nH]c2ccccc12)NC1CC1
c) CCOC(=O)C1=C(C)NC2=C(C(=O)c3ccccc32)C1c1cccc2ccccc12
d) CSc1ncccc1C(=O)Nc1ccc(C)cn1
e) Clc1cccc(C2NCCc3[nH]cnc32)c1
Answer: e. Clc1cccc(C2NCCc3[nH]cnc32)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1cccc(C2NCCc3[nH]cnc32)c1
Clc1cccc(C2NCCc3[nH]cnc32)c1
4-(3-chlorophenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine